[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Prescription Gastrointestinal Drugs Market Research Report 2024(Status and Outlook)

September 2024 | 112 pages | ID: GCEE7F8DC3ADEN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview

The prescription drugs are widely used in the treatment of gastrointestinal disorders, crohn’s disease, ulcerative colitis, irritable bowel syndrome, diverticular disease, constipation, celiac disease, short bowel syndrome, diarrhea, intestinal obstruction and digestive enzyme disorders.

The global Prescription Gastrointestinal Drugs market size was estimated at USD 28810 million in 2023 and is projected to reach USD 41632.02 million by 2030, exhibiting a CAGR of 5.40% during the forecast period.

North America Prescription Gastrointestinal Drugs market size was USD 7507.06 million in 2023, at a CAGR of 4.63% during the forecast period of 2024 through 2030.

This report provides a deep insight into the global Prescription Gastrointestinal Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Prescription Gastrointestinal Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Prescription Gastrointestinal Drugs market in any manner.

Global Prescription Gastrointestinal Drugs Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

AstraZeneca

Axcan Pharmaceuticals

Eisai

GlaxoSmithKline

Merck

Salix Pharmaceuticals

Market Segmentation (by Type)

Oral

Topical

Market Segmentation (by Application)

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Prescription Gastrointestinal Drugs Market
  • Overview of the regional outlook of the Prescription Gastrointestinal Drugs Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Prescription Gastrointestinal Drugs Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Prescription Gastrointestinal Drugs
1.2 Key Market Segments
  1.2.1 Prescription Gastrointestinal Drugs Segment by Type
  1.2.2 Prescription Gastrointestinal Drugs Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 PRESCRIPTION GASTROINTESTINAL DRUGS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Prescription Gastrointestinal Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
  2.1.2 Global Prescription Gastrointestinal Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 PRESCRIPTION GASTROINTESTINAL DRUGS MARKET COMPETITIVE LANDSCAPE

3.1 Global Prescription Gastrointestinal Drugs Sales by Manufacturers (2019-2024)
3.2 Global Prescription Gastrointestinal Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Prescription Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Prescription Gastrointestinal Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Prescription Gastrointestinal Drugs Sales Sites, Area Served, Product Type
3.6 Prescription Gastrointestinal Drugs Market Competitive Situation and Trends
  3.6.1 Prescription Gastrointestinal Drugs Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Prescription Gastrointestinal Drugs Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 PRESCRIPTION GASTROINTESTINAL DRUGS INDUSTRY CHAIN ANALYSIS

4.1 Prescription Gastrointestinal Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PRESCRIPTION GASTROINTESTINAL DRUGS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 PRESCRIPTION GASTROINTESTINAL DRUGS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Prescription Gastrointestinal Drugs Sales Market Share by Type (2019-2024)
6.3 Global Prescription Gastrointestinal Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Prescription Gastrointestinal Drugs Price by Type (2019-2024)

7 PRESCRIPTION GASTROINTESTINAL DRUGS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Prescription Gastrointestinal Drugs Market Sales by Application (2019-2024)
7.3 Global Prescription Gastrointestinal Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Prescription Gastrointestinal Drugs Sales Growth Rate by Application (2019-2024)

8 PRESCRIPTION GASTROINTESTINAL DRUGS MARKET SEGMENTATION BY REGION

8.1 Global Prescription Gastrointestinal Drugs Sales by Region
  8.1.1 Global Prescription Gastrointestinal Drugs Sales by Region
  8.1.2 Global Prescription Gastrointestinal Drugs Sales Market Share by Region
8.2 North America
  8.2.1 North America Prescription Gastrointestinal Drugs Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Prescription Gastrointestinal Drugs Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Prescription Gastrointestinal Drugs Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Prescription Gastrointestinal Drugs Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Prescription Gastrointestinal Drugs Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 AstraZeneca
  9.1.1 AstraZeneca Prescription Gastrointestinal Drugs Basic Information
  9.1.2 AstraZeneca Prescription Gastrointestinal Drugs Product Overview
  9.1.3 AstraZeneca Prescription Gastrointestinal Drugs Product Market Performance
  9.1.4 AstraZeneca Business Overview
  9.1.5 AstraZeneca Prescription Gastrointestinal Drugs SWOT Analysis
  9.1.6 AstraZeneca Recent Developments
9.2 Axcan Pharmaceuticals
  9.2.1 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Basic Information
  9.2.2 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product Overview
  9.2.3 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product Market Performance
  9.2.4 Axcan Pharmaceuticals Business Overview
  9.2.5 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs SWOT Analysis
  9.2.6 Axcan Pharmaceuticals Recent Developments
9.3 Eisai
  9.3.1 Eisai Prescription Gastrointestinal Drugs Basic Information
  9.3.2 Eisai Prescription Gastrointestinal Drugs Product Overview
  9.3.3 Eisai Prescription Gastrointestinal Drugs Product Market Performance
  9.3.4 Eisai Prescription Gastrointestinal Drugs SWOT Analysis
  9.3.5 Eisai Business Overview
  9.3.6 Eisai Recent Developments
9.4 GlaxoSmithKline
  9.4.1 GlaxoSmithKline Prescription Gastrointestinal Drugs Basic Information
  9.4.2 GlaxoSmithKline Prescription Gastrointestinal Drugs Product Overview
  9.4.3 GlaxoSmithKline Prescription Gastrointestinal Drugs Product Market Performance
  9.4.4 GlaxoSmithKline Business Overview
  9.4.5 GlaxoSmithKline Recent Developments
9.5 Merck
  9.5.1 Merck Prescription Gastrointestinal Drugs Basic Information
  9.5.2 Merck Prescription Gastrointestinal Drugs Product Overview
  9.5.3 Merck Prescription Gastrointestinal Drugs Product Market Performance
  9.5.4 Merck Business Overview
  9.5.5 Merck Recent Developments
9.6 Salix Pharmaceuticals
  9.6.1 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Basic Information
  9.6.2 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product Overview
  9.6.3 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product Market Performance
  9.6.4 Salix Pharmaceuticals Business Overview
  9.6.5 Salix Pharmaceuticals Recent Developments

10 PRESCRIPTION GASTROINTESTINAL DRUGS MARKET FORECAST BY REGION

10.1 Global Prescription Gastrointestinal Drugs Market Size Forecast
10.2 Global Prescription Gastrointestinal Drugs Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Prescription Gastrointestinal Drugs Market Size Forecast by Country
  10.2.3 Asia Pacific Prescription Gastrointestinal Drugs Market Size Forecast by Region
  10.2.4 South America Prescription Gastrointestinal Drugs Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Prescription Gastrointestinal Drugs by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global Prescription Gastrointestinal Drugs Market Forecast by Type (2025-2030)
  11.1.1 Global Forecasted Sales of Prescription Gastrointestinal Drugs by Type (2025-2030)
  11.1.2 Global Prescription Gastrointestinal Drugs Market Size Forecast by Type (2025-2030)
  11.1.3 Global Forecasted Price of Prescription Gastrointestinal Drugs by Type (2025-2030)
11.2 Global Prescription Gastrointestinal Drugs Market Forecast by Application (2025-2030)
  11.2.1 Global Prescription Gastrointestinal Drugs Sales (Kilotons) Forecast by Application
  11.2.2 Global Prescription Gastrointestinal Drugs Market Size (M USD) Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Prescription Gastrointestinal Drugs Market Size Comparison by Region (M USD)
Table 5. Global Prescription Gastrointestinal Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Prescription Gastrointestinal Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Prescription Gastrointestinal Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Prescription Gastrointestinal Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Gastrointestinal Drugs as of 2022)
Table 10. Global Market Prescription Gastrointestinal Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Prescription Gastrointestinal Drugs Sales Sites and Area Served
Table 12. Manufacturers Prescription Gastrointestinal Drugs Product Type
Table 13. Global Prescription Gastrointestinal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Prescription Gastrointestinal Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Prescription Gastrointestinal Drugs Market Challenges
Table 22. Global Prescription Gastrointestinal Drugs Sales by Type (Kilotons)
Table 23. Global Prescription Gastrointestinal Drugs Market Size by Type (M USD)
Table 24. Global Prescription Gastrointestinal Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Prescription Gastrointestinal Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Prescription Gastrointestinal Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Prescription Gastrointestinal Drugs Market Size Share by Type (2019-2024)
Table 28. Global Prescription Gastrointestinal Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Prescription Gastrointestinal Drugs Sales (Kilotons) by Application
Table 30. Global Prescription Gastrointestinal Drugs Market Size by Application
Table 31. Global Prescription Gastrointestinal Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Prescription Gastrointestinal Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Prescription Gastrointestinal Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Prescription Gastrointestinal Drugs Market Share by Application (2019-2024)
Table 35. Global Prescription Gastrointestinal Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Prescription Gastrointestinal Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Prescription Gastrointestinal Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Prescription Gastrointestinal Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Prescription Gastrointestinal Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Prescription Gastrointestinal Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Prescription Gastrointestinal Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Prescription Gastrointestinal Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. AstraZeneca Prescription Gastrointestinal Drugs Basic Information
Table 44. AstraZeneca Prescription Gastrointestinal Drugs Product Overview
Table 45. AstraZeneca Prescription Gastrointestinal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. AstraZeneca Business Overview
Table 47. AstraZeneca Prescription Gastrointestinal Drugs SWOT Analysis
Table 48. AstraZeneca Recent Developments
Table 49. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Basic Information
Table 50. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product Overview
Table 51. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Axcan Pharmaceuticals Business Overview
Table 53. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs SWOT Analysis
Table 54. Axcan Pharmaceuticals Recent Developments
Table 55. Eisai Prescription Gastrointestinal Drugs Basic Information
Table 56. Eisai Prescription Gastrointestinal Drugs Product Overview
Table 57. Eisai Prescription Gastrointestinal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Eisai Prescription Gastrointestinal Drugs SWOT Analysis
Table 59. Eisai Business Overview
Table 60. Eisai Recent Developments
Table 61. GlaxoSmithKline Prescription Gastrointestinal Drugs Basic Information
Table 62. GlaxoSmithKline Prescription Gastrointestinal Drugs Product Overview
Table 63. GlaxoSmithKline Prescription Gastrointestinal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline Recent Developments
Table 66. Merck Prescription Gastrointestinal Drugs Basic Information
Table 67. Merck Prescription Gastrointestinal Drugs Product Overview
Table 68. Merck Prescription Gastrointestinal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Merck Business Overview
Table 70. Merck Recent Developments
Table 71. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Basic Information
Table 72. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product Overview
Table 73. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Salix Pharmaceuticals Business Overview
Table 75. Salix Pharmaceuticals Recent Developments
Table 76. Global Prescription Gastrointestinal Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 77. Global Prescription Gastrointestinal Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 78. North America Prescription Gastrointestinal Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 79. North America Prescription Gastrointestinal Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 80. Europe Prescription Gastrointestinal Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 81. Europe Prescription Gastrointestinal Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 82. Asia Pacific Prescription Gastrointestinal Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 83. Asia Pacific Prescription Gastrointestinal Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 84. South America Prescription Gastrointestinal Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 85. South America Prescription Gastrointestinal Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 86. Middle East and Africa Prescription Gastrointestinal Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 87. Middle East and Africa Prescription Gastrointestinal Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 88. Global Prescription Gastrointestinal Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 89. Global Prescription Gastrointestinal Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 90. Global Prescription Gastrointestinal Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 91. Global Prescription Gastrointestinal Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 92. Global Prescription Gastrointestinal Drugs Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Prescription Gastrointestinal Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Prescription Gastrointestinal Drugs Market Size (M USD), 2019-2030
Figure 5. Global Prescription Gastrointestinal Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Prescription Gastrointestinal Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Prescription Gastrointestinal Drugs Market Size by Country (M USD)
Figure 11. Prescription Gastrointestinal Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Prescription Gastrointestinal Drugs Revenue Share by Manufacturers in 2023
Figure 13. Prescription Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Prescription Gastrointestinal Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Prescription Gastrointestinal Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Prescription Gastrointestinal Drugs Market Share by Type
Figure 18. Sales Market Share of Prescription Gastrointestinal Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Prescription Gastrointestinal Drugs by Type in 2023
Figure 20. Market Size Share of Prescription Gastrointestinal Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Prescription Gastrointestinal Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Prescription Gastrointestinal Drugs Market Share by Application
Figure 24. Global Prescription Gastrointestinal Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Prescription Gastrointestinal Drugs Sales Market Share by Application in 2023
Figure 26. Global Prescription Gastrointestinal Drugs Market Share by Application (2019-2024)
Figure 27. Global Prescription Gastrointestinal Drugs Market Share by Application in 2023
Figure 28. Global Prescription Gastrointestinal Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Prescription Gastrointestinal Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Prescription Gastrointestinal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Prescription Gastrointestinal Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Prescription Gastrointestinal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Prescription Gastrointestinal Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Prescription Gastrointestinal Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Prescription Gastrointestinal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Prescription Gastrointestinal Drugs Sales Market Share by Country in 2023
Figure 37. Germany Prescription Gastrointestinal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Prescription Gastrointestinal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Prescription Gastrointestinal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Prescription Gastrointestinal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Prescription Gastrointestinal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Prescription Gastrointestinal Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Prescription Gastrointestinal Drugs Sales Market Share by Region in 2023
Figure 44. China Prescription Gastrointestinal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Prescription Gastrointestinal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Prescription Gastrointestinal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Prescription Gastrointestinal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Prescription Gastrointestinal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Prescription Gastrointestinal Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Prescription Gastrointestinal Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Prescription Gastrointestinal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Prescription Gastrointestinal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Prescription Gastrointestinal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Prescription Gastrointestinal Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Prescription Gastrointestinal Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Prescription Gastrointestinal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Prescription Gastrointestinal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Prescription Gastrointestinal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Prescription Gastrointestinal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Prescription Gastrointestinal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Prescription Gastrointestinal Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Prescription Gastrointestinal Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Prescription Gastrointestinal Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Prescription Gastrointestinal Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Prescription Gastrointestinal Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Prescription Gastrointestinal Drugs Market Share Forecast by Application (2025-2030)


More Publications